Journal of Medicinal Chemistry p. 5623 - 5642 (2018)
Update date:2022-08-15
Topics:
Wang, Feng
Jeon, Kyu Ok
Salovich, James M.
Macdonald, Jonathan D.
Alvarado, Joseph
Gogliotti, Rocco D.
Phan, Jason
Olejniczak, Edward T.
Sun, Qi
Wang, Shidong
Camper, Demarco
Yuh, Joannes P.
Shaw, J. Grace
Sai, Jiqing
Rossanese, Olivia W.
Tansey, William P.
Stauffer, Shaun R.
Fesik, Stephen W.
WDR5 is a chromatin-regulatory scaffold protein overexpressed in various cancers and a potential epigenetic drug target for the treatment of mixed-lineage leukemia. Here, we describe the discovery of potent and selective WDR5-WIN-site inhibitors using fragment-based methods and structure-based design. NMR-based screening of a large fragment library identified several chemically distinct hit series that bind to the WIN site within WDR5. Members of a 6,7-dihydro-5H-pyrrolo[1,2-a]imidazole fragment class were expanded using a structure-based design approach to arrive at lead compounds with dissociation constants <10 nM and micromolar cellular activity against an AML-leukemia cell line. These compounds represent starting points for the discovery of clinically useful WDR5 inhibitors for the treatment of cancer.
View MoreWuhan Kemi-Works Chemical Co., Ltd
website:http://www.kemiworks.com
Contact:86-27-85736489
Address:Rm. 1503, No. 164, Jianghan North Rd., Wuhan, 430022 China
Tianjin Crest Pharmaceutical R&D Co., Ltd. (Tianjin Yao Technology Development Co., Ltd.)(expird)
Contact:+86-22-66211386
Address:Building B5-405, No, 80 4th Avenue, TEDA, Tianjin, China P.R. 300457
website:http://www.josunpharma.com
Contact:+86-311-80715268 80766839
Address:No.39, Zhaiying Street, Shijaizhuang,Hebei,China
Contact:+86-29-88710656
Address:South Tai bai Road, High Tech Development Zone, Xi'an China
Shanghai Yingrui Biopharma Co., Ltd
Contact:021-3358 8661*8003
Address:shanghai
Doi:10.1007/BF00763697
(1986)Doi:10.1080/00397919608003762
(1996)Doi:10.1016/j.tet.2012.09.087
(2012)Doi:10.1021/acscatal.8b00923
(2018)Doi:10.1248/cpb.34.1950
(1986)Doi:10.1016/j.tet.2008.08.010
(2008)